Viam affectare Olympo

308,58 (14,30%)

How does this work? Site map Contacts Database

Ru

Viam affectare Olympo

308,58 (14,30%)

Translate Page Original Page

Medicine and Health

Current Clinical Trials

Antineoplastic Agents

Current Clinical Trials

Diseases Rare diseases Drug trials

All medicine categories

Antineoplastic Agents

Azathioprine 1 investigation
Bevacizumab 3 research
Busulfan 1 investigation
Capecitabine 1 investigation
Cyclophosphamide 1 investigation
Dabrafenib 1 investigation
Dexamethasone 4 research

Docetaxel 2 research
Entinostat 1 investigation
Fludarabine 1 investigation
Fulvestrant 1 investigation
Lenalidomide 1 investigation
Melphalan 1 investigation
Paclitaxel 2 research

Porfiromycin 2 research
Prednisone 1 investigation
Rituximab 1 investigation
Temozolomide 1 investigation
Tipifarnib 1 investigation
Trametinib 1 investigation
Trastuzumab 1 investigation

Site Map